Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New prostaglandin I2 receptor antagonists in early development at Roche

Dec. 14, 2004

RxGen awarded phase I of fast track SBIR grant for Parkinson's research

Dec. 14, 2004

Pilot pharmacokinetic study for zolpidem lingual spray formulation

Dec. 14, 2004

Update on the pharmacokinetics of erlosamide in healthy volunteers

Dec. 14, 2004

Roche claims CRF receptor antagonists and their use in stress-related disorders, anxiety, etc.

Dec. 13, 2004

Enrollment under way in pivotal MS study of MBP-8298

Dec. 13, 2004

Update on the safety and antiepileptic effects of UCB-34714

Dec. 13, 2004

Immune Response Corporation expands MS development program

Dec. 13, 2004

U.S. launch of DepoDur

Dec. 13, 2004

Wyeth responds to U.K. MHRA's action on Efexor

Dec. 13, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...